Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
THERAPEUTIC AGENT FOR NK CELL TUMOR
Document Type and Number:
WIPO Patent Application WO/2023/204181
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing a therapeutic agent for NK cell tumor. According to the present invention, a therapeutic agent for NK cell tumor is provided, which comprises a substance capable of recognizing a transferrin receptor.

Inventors:
YOSHIDA KOTANI AI (JP)
UKAI YOSHINORI (JP)
MATSUURA TADASHI (JP)
ISHII KEISUKE (JP)
Application Number:
PCT/JP2023/015337
Publication Date:
October 26, 2023
Filing Date:
April 17, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TOKAI UNIV EDUCATIONAL SYSTEM (JP)
PERSEUS PROTEOMICS INC (JP)
International Classes:
A61K45/00; A61K39/395; A61P35/02; C07K16/28; C12N15/13
Domestic Patent References:
WO2014073641A12014-05-15
Other References:
ZHANG LILIN, NOMURA FUMIKO, AIKAWA YOICHI, KUROSAWA YOSHIKAZU, MORISHITA KAZUHIRO, SUDO YUKIO: "Abstract 5586: PPMX-T003, a fully human anti-TfR1 antibody with potent efficacy against hematologic malignancies", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 77, no. 13_Supplement, 1 July 2017 (2017-07-01), US, pages 5586 - 5586, XP093101609, ISSN: 0008-5472, DOI: 10.1158/1538-7445.AM2017-5586
MAKOTO SASAKI; KOICHI SUGIMOTO; SHIMPEI KAWAHARA; HAJIME YASUDA; HIROKO SUTO; KAZUO OSHIMI: "Rapid elimination of circulating leukemia cells with a small dose of alemtuzumab in refractory aggressive NK‐cell leukemia", EUROPEAN JOURNAL OF HAEMATOLOGY, MUNSKGAARD, COPENHAGEN., DK, vol. 78, no. 6, 14 March 2007 (2007-03-14), DK , pages 545 - 545, XP071759300, ISSN: 0902-4441, DOI: 10.1111/j.1600-0609.2007.00855.x
Attorney, Agent or Firm:
SIKS & CO. (JP)
Download PDF: